Logo

Scipher Medicine: Slava Akmaev

Mar 24, 2020

Scipher Medicine has appointed Slava Akmaev as its chief technology officer, a role that includes overseeing the company's data science and technology teams, ensuring efficient data on-boarding, quality control, and rapid analytics across Scipher's pipeline of precision diagnostics.

Akmaev is a leader in applying high-throughput molecular technology, machine learning, artificial intelligence, and data analysis within the life sciences and healthcare industry, and routinely publishes in the peer-reviewed scientific literature. Prior to joining Scipher, he was the senior vice president and chief analytics officer at Berg, where he cofounded and led Berg Analytics. Prior to that he helped commercialize four molecular diagnostic tests at Genzyme Genetics. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.